used the risk score method to identify 3 genes associated with adverse prognosis of pancreatic adenocarcinoma (PAAD), ERAP2, CKLF and EREG, and constructed a nomogram based on clinical features and risk score for individualized prognosis prediction (51). This evidence concerns the gene EREG and pancreatic adenocarcinoma.